Russian Gangs Make Millions by Selling Fake Tamiflu Online
An investigation by the British security company Sophos has revealed that Russian cyber criminals are making millions of dollars by selling counterfeit Tamiflu online.
Bogus online pharmacies, with names such as Canadian Pharmacy or European Pharmacy, carry forged copies of certificates guaranteeing authenticity. The Russian gangs are marketing their products by sending billions of spam messages selling Tamiflu, and other drugs.
In addition to paying money for useless or even dangerous drugs, the investigators say that customers are putting themselves at risk of identity fraud.
Sophos has discovered that the top five countries purchasing counterfeit Tamiflu are the United States, Germany, United Kingdom, Canada and France and that cyber criminals make between EUR 11,240 (USD 16,386) and EUR 67,442 (USD 98,338) a day.
For more information, please contact Jelena Jankovic in our Balkan Regional Office.
Source: Times Online
Read more news on Russia or . Get our latest IP news or browse IP News Eastern Europe Archives.
Share:
December 2009 News
- Four New Laws to Enter into Force in Serbia by the New Year
- Russian Gangs Make Millions by Selling Fake Tamiflu Online
- French Champagne Producer Defends its Right to Cristal Trademark in Russia
- Estonian Software Pirate to Pay EUR 100.000 in Damages to Five Software Companies
- Trademarks and Geographical Denominations Gazette Issued in Azerbaijan
- Ukrainian Cyrillic Domain to Start Operating by March 2010
- Romanian Customs Seize 20 Tons of Fake Perfume
- Bulgarian Alcohol Producer Fined for Unfair Competition
- Bulgarian Company Fined for Trade Dress Infringement and Unfair Competition
- Microsoft Launches Anti-Piracy Program in Russia
- Macedonian Police Seize Counterfeit Alcoholic Drinks
- Bulgarians Arrested in Moscow On Piracy Charges
- Macedonian Customs Seize Counterfeit Goods
- Bulgarian Police Seize Pirated Software, Films and Music
- Russia’s Textile Industry Grows After Shutdown of Counterfeit Goods Market
- European Patent Extension to Montenegro Expected Soon